Categories
Publications & Presentations
Discover the main highlights of our industry in our latest publications.
Access to Care
Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.
Safety & Quality
Learn more about the regulatory policies and the Association’s voluntary standards for safety & quality standards.
Plasma Collection & Manufacturing
Learn more about plasma collection and discover certified plasma centers near you.
The Source Magazine
Subscribe to the international magazine of the plasma protein therapeutics industry.
Plasma FAQS
Get answers about plasma therapies and the processes surrounding donation and collection procedures.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Dec 11, 2020
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
PPTA congratulates the province of Alberta for formally adopting the Voluntary Blood Donations Repeal Act, which repeals the existing ban on compensated plasma donation. This landmark legislation allows the citizens of Alberta to join the millions of source plasma donors worldwide who receive a modest compensation for their commitment to providing the starting material for lifesaving therapies to treat the patients who need them. These therapies are relied upon by people facing rare, serious, and life-threatening conditions and are often the only treatment for this vulnerable population.
All
PPTA statements
Dec 11, 2020
PPTA Statement on Alberta’s Passing of the Voluntary Blood Donation Repeal Act
PPTA congratulates the province of Alberta for formally adopting the Voluntary Blood Donations Repeal Act, which repeals the existing ban on compensated plasma donation. This landmark legislation allows the citizens of Alberta to join the millions of source plasma donors worldwide who receive a modest compensation for their commitment to providing the starting material for lifesaving therapies to treat the patients who need them. These therapies are relied upon by people facing rare, serious, and life-threatening conditions and are often the only treatment for this vulnerable population.
All
PPTA statements
Dec 9, 2020
Europe's Need for More Plasma – Event Report
An online roundtable event entitled “Europe’s need for more plasma – before, during and after Covid-19: challenges and possible solutions”, organized and co-hosted by Member of the European Parliament (MEP) Simona Bonafè, (S&D, Italy) and MEP César Luena (S&D, Spain), and moderated by Peter O’Donnell, a Freelance reporter, took place on December 9, 2020.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9077ae02d4cd30a5374_Event%20report%20on%20Europe%20s%20need%20for%20more%20plasma_%2009.12.2020.pdf
Dec 9, 2020
Europe's Need for More Plasma – Event Report
An online roundtable event entitled “Europe’s need for more plasma – before, during and after Covid-19: challenges and possible solutions”, organized and co-hosted by Member of the European Parliament (MEP) Simona Bonafè, (S&D, Italy) and MEP César Luena (S&D, Spain), and moderated by Peter O’Donnell, a Freelance reporter, took place on December 9, 2020.
All
Presentation
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6454e9077ae02d4cd30a5374_Event%20report%20on%20Europe%20s%20need%20for%20more%20plasma_%2009.12.2020.pdf
Dec 1, 2020
The Source Winter 2020
Magazine of the plasma protein therapeutics industry - Winter 2020
All
The Source Magazine
https://drive.google.com/file/d/1UOI5Vo3ICyAgqZ_pLX7NEzgNhugvJEWb/view?usp=sharing
Dec 1, 2020
The Source Winter 2020
Magazine of the plasma protein therapeutics industry - Winter 2020
All
The Source Magazine
https://drive.google.com/file/d/1UOI5Vo3ICyAgqZ_pLX7NEzgNhugvJEWb/view?usp=sharing
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
Nov 23, 2020
CDC Advisory Committee on Immunization Practices Comments on Vaccine Prioritization
PPTA represents manufacturers of plasma protein therapies and plasma collection centers. Last year, U.S. centers collected over 50 million plasma donations, which were manufactured into therapies for thousands of Americans and others with rare, life threatening and frequently chronic conditions.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453fa08e6668e67538ef9b4_CDC%20Advisory%20Committee%20on%20Immunization%20Practices%20Comments%20on%20Vaccine%20Prioritization.pdf
No results found